Thanks for the helpful reply Marge. Unfortunately, the transcription factor that I ChIP-ed for is not well studied so there is very little preliminary data to compare against.
I am aware of the blacklisted regions and while I did not remove these from my analysis, I overlaid these with my sets of sequence tracks and only a handful of the peaks fall under a blacklisted area and so I suspect there is something else at play here.
I did do some ChIP-qPCR prior to sending samples for sequencing. Obviously, without any previously published/confirmed binding sites for my TF of interest this is like trying to find the needle in the proverbial haystack. From the qPCR, I did see some enrichment of predicted binding sites in the ChIP samples relative to isotype control IP and so I was hoping the ChIP-seq might confirm these as well as identifying new sites. Unfortunately, with the benefit of hindsight, I think what the qPCR may have shown was simply increased non-specific chromatin pull down in the antibody sample when compared to an isotype antibody.
I was referring to uniquely mapped sequences and so this is something that I am really looking to improve to see if it can make some of the data less murky.
Hello fraseriainyoung!
It appears that your post has been cross-posted to another site: http://seqanswers.com/forums/showthread.php?t=72250
This is typically not recommended as it runs the risk of annoying people in both communities.
Some ideas :
Thanks Carlo.
Unfortunately, there are no known binding sites to compare my data against. I am going to check correlation between the samples with DeepTools. The peaks are randomly distributed with the majority featuring in intergenic regions. The fastQC profiles for each of the samples, while not perfect, were about as good as you can expect for the low starting amount of DNA from a ChIP. The only warning flashed up was over PCR duplication levels.
Are you using a Clontech kit by any chance?